EyePoint, Inc. (EYPT) stock
EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$0.23−0.03 (-11.36%)
Close on Nov 20, 2026Market cap $20.19MP/E –Yield –
EyePoint shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
EyePoint's shares outstanding was 0M at Jun 30, 2026. For fiscal 2025 it was 0M, up 30.1% from the year before. Over ten years it grew -30.4% a year on average. The highest annual figure on record is 37M in fiscal 2022.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0M | +30.1% |
| FY2024 | Dec 31, 2024 | 0M | +44.7% |
| FY2023 | Dec 31, 2023 | 0M | -99.9% |
| FY2022 | Dec 31, 2022 | 37M | +29.8% |
| FY2021 | Dec 31, 2021 | 29M | +124.0% |
| FY2020 | Dec 31, 2020 | 13M | +177.7% |
| FY2018 | Jun 30, 2018 | 5M | +30.8% |
| FY2017 | Jun 30, 2017 | 4M | +11.8% |
| FY2016 | Jun 30, 2016 | 3M | +3.4% |
| FY2015 | Jun 30, 2015 | 3M | +11.4% |
| FY2014 | Jun 30, 2014 | 3M | +19.1% |
| FY2013 | Jun 30, 2013 | 2M | +10.8% |
| FY2012 | Jun 30, 2012 | 2M | +6.7% |
| FY2011 | Jun 30, 2011 | 2M | +3.1% |
| FY2010 | Jun 30, 2010 | 2M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | 0M | +23.8% |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | 0M | +23.3% |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | 0M | +28.7% |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 0M | +28.9% |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 0M | +31.4% |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | 0M | -99.9% |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 0M | -99.8% |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 0M | -99.9% |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 0M | +41.9% |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 53M | +41.7% |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | 38M | +2.7% |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | 38M | +0.7% |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 0M | -99.9% |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 37M | +14.1% |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 37M | +29.8% |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 37M | +29.8% |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 37M | +50.6% |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | 33M | +125.6% |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 29M | +124.8% |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 29M | +130.4% |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 25M | +114.1% |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 15M | +162.0% |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 13M | +180.3% |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 12M | +180.2% |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 12M | +193.0% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | 6M | +43.2% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | 5M | +32.8% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | 4M | +30.3% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | 4M | +15.4% |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | 4M | +113144.5% |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | 3M | +102362.7% |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | 3M | +115990.4% |
| Q1 FY2017CQ3 2016 | Sep 30, 2016 | 3M | +116062.5% |
| Q4 FY2016CQ2 2016 | Jun 30, 2016 | 0M | -99.9% |
| Q3 FY2016CQ1 2016 | Mar 31, 2016 | 0M | -99.9% |
| Q2 FY2016CQ4 2015 | Dec 31, 2015 | 0M | – |
| Q1 FY2016CQ3 2015 | Sep 30, 2015 | 0M | – |
| Q4 FY2015CQ2 2015 | Jun 30, 2015 | 3M | – |
| Q3 FY2015CQ1 2015 | Mar 31, 2015 | 3M | – |
See a number that looks wrong?